Cutler Group LP Aerie Pharmaceuticals Inc Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2018 Nov 07, 2018	SELL	$56.15 - $73.9 $561,500 - $739,000	-10,000 Reduced 62.11%	6,100 $5,000
Q2 2018 Aug 10, 2018	BUY	$47.85 - $70.45 $416,295 - $612,915	8,700 Added 117.57%	16,100 $11,000
Q1 2018 May 11, 2018	SELL	$51.15 - $61.0 $624,030 - $744,200	-12,200 Reduced 62.24%	7,400 $20,000
Q3 2017 Oct 17, 2017	BUY	$48.6 - $60.1 $952,560 - $1.18 Million	19,600	19,600 $102,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.